Staar Surgical Co. (NASDAQ:STAA) has a beta value of 0.84 and has seen 1.45 million shares traded in the last trading session. The company, currently valued at $2.42B, closed the last trade at $49.49 per share which meant it gained $0.81 on the day or 1.66% during that session. The STAA stock price is -47.77% off its 52-week high price of $73.13 and 46.13% above the 52-week low of $26.66. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.01 million shares traded. The 3-month trading volume is 758.88K shares.
Staar Surgical Co. (NASDAQ:STAA) trade information
Sporting 1.66% in the green in last session, the stock has traded in the green over the last five days, when the STAA stock price touched $49.49 or saw a rise of 0.22%. Year-to-date, Staar Surgical Co. shares have moved 58.57%, while the 5-day performance has seen it change 26.77%. Over the past 30 days, the shares of Staar Surgical Co. (NASDAQ:STAA) have changed 40.96%. Short interest in the company has seen 5.43 million shares shorted with days to cover at 7.44.
Staar Surgical Co. (STAA) estimates and forecasts
Figures show that Staar Surgical Co. shares have underperformed across the wider relevant industry. The company’s shares have gained 30.65% over the past 6 months, with this year growth rate of -48.70%, compared to 7.50% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are -83.30% and -37.50% for the next quarter. Revenue growth from the last financial year stood is estimated to be 4.70%.
11 analysts offering their estimates for the company have set an average revenue estimate of $73.07 million for the current quarter. 11 have an estimated revenue figure of $95.1 million for the next quarter concluding in Jun 2024. Year-ago sales stood $66.96 million and $92.31 million respectively for this quarter and the next, and analysts expect sales will grow by 9.10% for the current quarter and 3.00% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 31.51% over the past 5 years. Earnings growth for 2024 is a modest -45.19% while over the next 5 years, the company’s earnings are expected to increase by 30.00%.
STAA Dividends
Staar Surgical Co. is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Staar Surgical Co. (NASDAQ:STAA)’s Major holders
Insiders own 0.79% of the company shares, while shares held by institutions stand at 107.71% with a share float percentage of 108.56%. Investors are also buoyed by the number of investors in a company, with Staar Surgical Co. having a total of 306 institutions that hold shares in the company. The top two institutional holders are Broadwood Capital, Inc. with over 8.78 million shares worth more than $461.73 million. As of Jun 29, 2023, Broadwood Capital, Inc. held 18.11% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 6.34 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $333.26 million and represent 13.07% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund. As of Sep 29, 2023, the former fund manager holds about 6.75% shares in the company for having 3.27 million shares of worth $131.57 million while later fund manager owns 1.5 million shares of worth $79.07 million as of Jun 29, 2023, which makes it owner of about 3.10% of company’s outstanding stock.
